Health Catalyst Stock Price, News & Analysis

Transformation Capital, a leader in digital health investments, announced the hiring of Jenna Ciotti as Vice President and Akhi Samant as Associate. Jenna, with experience at M33 Growth, will drive deal sourcing in digital health. She holds degrees from Yale University and focuses on improving health outcomes. Akhi, formerly at Goldman Sachs, brings expertise in technology and finance. Their addition aligns with Transformation's growth strategy and commitment to supporting innovative healthcare solutions, enhancing its impactful portfolio that includes notable companies like Health Catalyst (NASDAQ: HCAT).

Health Catalyst (HCAT) has partnered with Smarter Health, a Singapore-based healthcare technology company, to enhance data integration between payors and providers in Southeast Asia. This collaboration aims to address inefficiencies in medical billing and claims administration, leveraging Health Catalyst's Data Operating System and analytics capabilities. The partnership will facilitate improved transparency, service, and satisfaction within the healthcare ecosystem, ultimately supporting payors in evaluating care appropriateness and cost.

Health Catalyst (Nasdaq: HCAT) will announce its fourth quarter and full year 2020 operating results on February 25, 2021, after market close. A conference call will be held at 5 p.m. E.T. on the same day to discuss the results. The call can be accessed by U.S. participants at 1-877-295-1104 or 1-470-495-9486 internationally, using participant code 3180522. An online audio webcast will also be available. Health Catalyst specializes in data and analytics technology for healthcare, aiming for data-informed healthcare decisions.

Vitalware by Health Catalyst announced that its chargemaster management solution, VitalCDM, has ranked number one in the Revenue Cycle - Chargemaster Management category of the 2021 Best in KLAS Awards. This marks the third consecutive year VitalCDM has received this accolade. The recognition stemmed from client feedback in 2020, highlighting client satisfaction, functionality, and support. This achievement underscores VitalCDM's ability to enhance operational efficiency, ensure compliance, and improve reimbursement accuracy for hospitals amidst challenging economic conditions.

Health Catalyst (Nasdaq: HCAT) announced the re-appointment of Stephen Grossbart, Ph.D., as a member of the National Quality Forum's Primary Care and Chronic Illness Standing Committee on Jan. 11, 2021. Grossbart has been on the committee since 2017, contributing to significant healthcare quality measures amid ongoing challenges like the coronavirus pandemic. The committee oversees important healthcare measures, crucial for improving treatment outcomes for chronic and infectious diseases.

Transformation Capital Partners has launched its oversubscribed growth equity fund, Transformation Capital Fund II, with $500 million in capital commitments. This fund targets investments in commercial-stage digital health companies aiming to improve healthcare efficiency and consumer access. The firm, managing over $800 million across its funds, leverages its deep industry expertise and extensive healthcare network to support digital health entrepreneurs. The pandemic has accelerated the adoption of digital health solutions across the sector, positioning Transformation Capital as a key partner for growth.

Health Catalyst (Nasdaq: HCAT) will participate in the 39th Annual J.P. Morgan Healthcare Conference from January 11-14, 2021. CEO Dan Burton and CFO Bryan Hunt will present on January 11 at 5:20 p.m. EST. The conference will be held virtually, allowing broader access to healthcare stakeholders. An audio replay of their presentation will be available on the company's investor relations website. Health Catalyst is known for its advanced data and analytics solutions aimed at improving healthcare outcomes through informed decision-making.

Health Catalyst, a leading healthcare data and analytics provider, will participate in three upcoming investor conferences. Executives Patrick Nelli, Bryan Hunt, and Adam Brown are scheduled to present at the following events: the Piper Sandler 32^nd Annual Virtual Healthcare Conference on December 2, 2020; the Evercore ISI HealthCONx Conference on December 3, 2020, at 4:20 p.m. EST; and the Guggenheim Digital Health Virtual Conference on December 8, 2020, at 3:15 p.m. EST, with one-on-one meetings on December 9. More details are available on their investor relations page.

Health Catalyst, Inc. (Nasdaq: HCAT) reported its Q3 2020 financial results, showing a 20% year-over-year revenue increase to $47.2 million. Technology revenue grew by 32% to $28.0 million, while professional services revenue rose by 5%. Despite these gains, the company faced a net loss of $27.3 million, up from $21.4 million in Q3 2019. Adjusted EBITDA improved by 24%. Leadership changes were also announced, with Patrick Nelli becoming President, and Bryan Hunt appointed CFO, effective January 1, 2021. The company's outlook remains focused on growth and expanding customer relationships.